At the news
? BEARISHIMPACT 8/10 8-K filed Apr 17, 2026 at 17:16 ET
Revolution Medicines has issued $500 million in 0.50% convertible senior notes due 2033, following a series of capital raises totaling over $2.6 billion in the past week. This financing strengthens the company's balance sheet for R&D and corporate purposes, but adds significant dilution risk and leverage. The offering is part of an aggressive capital strategy that may signal a need for substantial funding, potentially for an acquisition or to extend runway amid high cash burn.
- Revolution Medicines issued $500 million in 0.50% convertible senior notes due 2033.
- This is the third capital raise in four days, following a $1.44 billion common stock offering and a $500 million convertible note offering.
- The notes are convertible into common stock at an initial conversion rate of 5.0302 shares per $1,000 principal amount.
- The company can redeem the notes after May 6, 2030, if the stock price exceeds 130% of the conversion price for a specified period.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access